These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15890418)

  • 1. Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspective.
    Mukhopadhyay S; Mukherjee TK
    Biochim Biophys Acta; 2005 Sep; 1745(2):145-55. PubMed ID: 15890418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
    Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
    Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
    Soro-Paavonen A; Zhang WZ; Venardos K; Coughlan MT; Harris E; Tong DC; Brasacchio D; Paavonen K; Chin-Dusting J; Cooper ME; Kaye D; Thomas MC; Forbes JM
    J Hypertens; 2010 Apr; 28(4):780-8. PubMed ID: 20186099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.
    Yamagishi SI; Nakamura N; Matsui T
    J Diabetes; 2017 Feb; 9(2):141-148. PubMed ID: 27556881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction.
    Neves D
    Free Radic Res; 2013 Aug; 47 Suppl 1():49-69. PubMed ID: 23822116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
    Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
    Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycation].
    Yamagishi S
    Nihon Rinsho; 2010 May; 68(5):809-13. PubMed ID: 20446573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptors for advanced glycation end products and their physiological and clinical significance].
    Pietkiewicz J; Seweryn E; Bartyś A; Gamian A
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():511-23. PubMed ID: 18936727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
    Lalla E; Lamster IB; Schmidt AM
    Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
    Wautier JL; Zoukourian C; Chappey O; Wautier MP; Guillausseau PJ; Cao R; Hori O; Stern D; Schmidt AM
    J Clin Invest; 1996 Jan; 97(1):238-43. PubMed ID: 8550841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide.
    Grossin N; Wautier MP; Wautier JL
    Biorheology; 2009; 46(1):63-72. PubMed ID: 19252229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
    Opatrna S; Popperlova A; Kalousová M; Zima T
    Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
    Lalla E; Lamster IB; Stern DM; Schmidt AM
    Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes.
    Lim SC; Caballero AE; Arora S; Smakowski P; Bashoff EM; Brown FM; Logerfo FW; Horton ES; Veves A
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4159-64. PubMed ID: 10566666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Pharmacol Res; 2012 Mar; 65(3):297-302. PubMed ID: 22100460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of advanced glycosylation end products in the pathogenesis of hypertension].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2003; 60(9):585-7. PubMed ID: 15065338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical properties and clinical significance of protein glycation products].
    Staniszewska M; Gamian A
    Postepy Hig Med Dosw; 2003; 57(2):123-47. PubMed ID: 12866352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.
    Aldini G; Vistoli G; Stefek M; Chondrogianni N; Grune T; Sereikaite J; Sadowska-Bartosz I; Bartosz G
    Free Radic Res; 2013 Aug; 47 Suppl 1():93-137. PubMed ID: 23560617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.